ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $316,000 | -63.6% | 3,403 | -76.6% | 0.00% | -50.0% |
| Q3 2021 | $868,000 | +21.9% | 14,569 | +39.5% | 0.00% | +33.3% |
| Q2 2021 | $712,000 | +73.7% | 10,446 | +76.9% | 0.00% | +50.0% |
| Q1 2021 | $410,000 | +210.6% | 5,904 | +244.7% | 0.00% | +100.0% |
| Q4 2020 | $132,000 | -90.7% | 1,713 | -91.0% | 0.00% | -88.9% |
| Q3 2020 | $1,424,000 | -57.7% | 19,035 | -64.4% | 0.01% | -67.9% |
| Q2 2020 | $3,365,000 | +41.2% | 53,457 | -5.8% | 0.03% | +27.3% |
| Q1 2020 | $2,383,000 | +127.0% | 56,749 | +145.4% | 0.02% | +120.0% |
| Q4 2019 | $1,050,000 | -40.0% | 23,121 | -39.6% | 0.01% | -28.6% |
| Q3 2019 | $1,751,000 | +1083.1% | 38,266 | +1417.3% | 0.01% | +1300.0% |
| Q2 2019 | $148,000 | -86.3% | 2,522 | -89.5% | 0.00% | -90.0% |
| Q1 2019 | $1,080,000 | +150.6% | 24,097 | +118.0% | 0.01% | +150.0% |
| Q4 2018 | $431,000 | +68.4% | 11,055 | +88.3% | 0.00% | +100.0% |
| Q2 2018 | $256,000 | -16.6% | 5,872 | -24.5% | 0.00% | 0.0% |
| Q1 2018 | $307,000 | +147.6% | 7,776 | +5.8% | 0.00% | +100.0% |
| Q2 2017 | $124,000 | – | 7,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |